Law360, New York (September 29, 2009, 2:59 PM ET) -- New Jersey's highest court on Tuesday upheld an award of $4.5 million in compensatory damages in a failure-to-warn suit brought by a diabetic man who suffered a heart attack after using Merck & Co. Inc.'s anti-inflammatory prescription drug Vioxx.
Weitz & Luxenberg PC announced Tuesday that the Supreme Court of New Jersey had just released its May 7 ruling in McDarby v. Merck, which upholds lower courts' decision to grant John McDarby and his widow, Irma McDarby, compensatory damages in a case involving Vioxx and its...
NJ Supreme Court Upholds $4.5M Vioxx Verdict
To view the full article, take a free trial now.
